Page 677 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 40 Thalassemia Syndromes 570.e9

403. Mucenski ML, McLain K, Kier AB, et al: A functional c-myb gene is 428. Taher AT, Porter JB, Viprakasit V, et al: Approaching low liver iron
required for normal murine fetal hepatic hematopoiesis. Cell 65:677, burden in chelated patients with non-transfusion-dependent thalas-
1991. semia: the safety profile of deferasirox. Eur J Haematol 92(6):521–526,
404. Bianchi E, Zini R, Salati S, et al: c-myb supports erythropoiesis through 2014.
the transactivation of KLF1 and LMO2 expression. Blood 116:e99, 429. Borgna Pignatti C, Carnelli V, Caruso V, et al: Thromboembolic events
2011. in beta thalassemia major: an Italian multicenter study. Acta Haematol
405. May C, Rivella S, Callegari J, et al: Therapeutic haemoglobin synthesis 99:76, 1998.
in beta-thalassaemic mice expressing lentivirus-encoded human beta- 430. Aessopos A, Farmakis D, Karagiorga M, et al: Cardiac involvement in
globin. Nature 406:82, 2000. thalassemia intermedia: a multicenter study. Blood 97:3411, 2001.
406. Rivella S, May C, Chadburn A, et al: A novel murine model of Cooley 431. Zalloua PA, Shbaklo H, Mourad YA, et al: Incidence of thrombo-
anemia and its rescue by lentiviral-mediated human beta-globin gene embolic events in Lebanese thalassemia intermedia patients. Thromb
transfer. Blood 101:2932, 2003. Haemost 89(4):767–768, 2003.
407. May C, Rivella S, Chadburn A, et al: Successful treatment of murine 432. Issaragrisil S, Piankigagum A, Wasi P: Spinal cord compression in
beta-thalassemia intermedia by transfer of the human beta-globin gene. thalassemia. Report of 12 cases and recommendations for treatment.
Blood 99:1902, 2002. Arch Intern Med 141:1033, 1981.
408. Lacerra G, Sierakowska H, Carestia C, et al: Restoration of hemoglobin 433. Ma SK, Au WY: Images in haematology. Hepatic haemopoiesis in
A synthesis in erythroid cells from peripheral blood of thalassemic beta-thalassaemia trait. Br J Haematol 107:1, 1999.
patients. Proc Natl Acad Sci USA 97:9591, 2000. 434. Saisorn I, Leewansangtong S, Sukpanichnant S, et al: Intrarenal extra-
409. Vacek MM, Ma H, Gemignani F, et al: High-level expression of medullary hematopoiesis as a renal mass in a patient with thalassemia.
hemoglobin A in human thalassemic erythroid progenitor cells follow- J Urol 165:507, 2001.
ing lentiviral vector delivery of an antisense snRNA. Blood 101:104, 435. Aarabi B, Haghshenas M, Rakeii V: Visual failure caused by suprasellar
2003. extramedullary hematopoiesis in beta thalassemia: case report. Neuro-
410. Baum C, Dullmann J, Li Z, et al: Side effects of retroviral gene transfer surgery 42:922, discussion 925–926, 1998.
into hematopoietic stem cells. Blood 101:2099, 2003. 436. Newton KL, McNeeley SG, Jr, Novick M: Extramedullary hemato-
411. Cavazzana-Calvo M, Payen E, Negre O, et al: Transfusion independence poiesis presenting as a pelvic mass in a patient with beta-thalassemia
and HMGA2 activation after gene therapy of human beta-thalassaemia. intermedia. JAMA 250:2178, 1983.
Nature 467:318, 2010. 437. Ibabao J, Kassapidis S, Demetis S, et al: Bilateral pleural effusions
412. Breda L, Gambari R, Rivella S: Gene therapy in thalassemia and in a beta-thalassemia intermedia patient with posterior mediastinal
hemoglobinopathies. Mediterr J Hematol Infect Dis 1:e2009008, extramedullary hematopoietic masses. Hemoglobin 23:249, 1999.
2009. 438. Kapelushnik J, Shalev H, Schulman H, et al: Upper airway obstruction-
413. Boulad F, Wang X, Qu J, et al: Safe mobilization of CD34+ cells related sleep apnea in a child with thalassemia intermedia. J Pediatr
in adults with β-thalassemia and validation of effective globin gene Hematol Oncol 23:525, 2001.
transfer for clinical investigation. Blood 123(10):1483–1486, 2014. 439. Porcaro AB, Novella G, Antoniolli SZ, et al: Adrenal extramedullary
414. Ye L, Chang JC, Lin C, et al: Induced pluripotent stem cells offer new hematopoiesis: report on a pediatric case and update of the literature.
approach to therapy in thalassemia and sickle cell anemia and option in Int Urol Nephrol 33:601, 2001.
prenatal diagnosis in genetic diseases. Proc Natl Acad Sci USA 106:9826, 440. Taher A, Skouri H, Jaber W, et al: Extramedullary hematopoiesis in a
2009. patient with beta-thalassemia intermedia manifesting as symptomatic
415. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from pleural effusion. Hemoglobin 25:363, 2001.
mouse embryonic and adult fibroblast cultures by defined factors. Cell 441. Tan TC, Tsao J, Cheung FC: Extramedullary haemopoiesis in thalas-
126:663, 2006. semia intermedia presenting as paraplegia. J Clin Neurosci 9:721, 2002.
416. Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent 442. Sorcinelli R, Cacace E, Del Piano M: Optic nerve compression by
induced pluripotent stem cells. Nature 448:313, 2007. extramedullary hematopoietic tissue in a patient suffering from beta-
417. Wernig M, Meissner A, Foreman R, et al: In vitro reprogramming of thalassemia intermedia. Metab Pediatr Syst Ophthalmol 22-23:5, 1999.
fibroblasts into a pluripotent ES-cell-like state. Nature 448:318, 2007. 443. Wood WG, Weatherall DJ, Hart GH, et al: Hematologic changes and
418. Friedman S, Hamilton RW, Schwartz E: Beta-thalassemia in the hemoglobin analysis beta thalassemia heterozygotes during the first year
American Negro. J Clin Invest 52:1453, 1973. of life. Pediatr Res 16:286, 1982.
419. Tamagnini GP, Lopes MC, Castanheira ME, et al: Beta + thalassemia– 444. Silvestroni E, Bianco I: A highly cost effective method of mass screening
Portuguese type: clinical, haematological and molecular studies of for thalassaemia. Br Med J (Clin Res Ed) 286:1007, 1983.
a newly defined form of beta thalassaemia. Br J Haematol 54:189, 445. Pippard MJ, Wainscoat JS: Erythrokinetics and iron status in het-
1983. erozygous beta thalassaemia, and the effect of interaction with alpha
420. Rachmilewitz EA, Giardina PJ: How I treat thalassemia. Blood thalassaemia. Br J Haematol 66:123, 1987.
118:3479, 2011. 446. Berman BW, Ritchey AK, Jekel JF, et al: Hematology of beta-thalassemia
421. Aksoy M, Bermek E, Almis G, et al: beta-Thalassemia intermedia trait–age-related developmental aspects and intrafamilial correlations. J
homozygous for normal hemoglobin A2 beta-thalassemia. Study in Pediatr 97:901, 1980.
four families. Acta Haematol 67:57, 1982. 447. Pearson HA, O’Brien RT, McIntosh S: Screening for thalassemia trait
422. Schwartz E: The silent carrier of beta thalassemia. N Engl J Med by electronic measurement of mean corpuscular volume. N Engl J Med
281:1327, 1969. 288:351, 1973.
423. Sbyrakis S, Karagiorga-Lagana M, Voskaki I, et al: A simple index 448. Hegde UM, Khunda S, MArsh GW, et al: Thalassaemia, iron, and
for initiating transfusion treatment in thalassaemia intermedia. Br J pregnancy. Br Med J 3:509, 1975.
Haematol 67:479, 1987. 449. Schuman JE, Tanser CL, Peloquin R, et al: The erythropoietic response
424. Aessopos A, Kati M, Meletis J: Thalassemia intermedia today: should to pregnancy in beta-thalassaemia minor. Br J Haematol 25:249,
patients regularly receive transfusions? Transfusion 47:792, 2007. 1973.
425. Pippard MJ, Callender ST, Warner GT, et al: Iron absorption and 450. Higgs DR: alpha-Thalassaemia. Baillieres Clin Haematol 6:117, 1993.
loading in beta-thalassaemia intermedia. Lancet 2:819, 1979. 451. Vichinsky EP: Clinical manifestations of α-thalassemia. Cold Spring
426. Cossu P, Toccafondi C, Vardeu F, et al: Iron overload and desferriox- Harb Perspect Med 3(5):a011742, 2013.
amine chelation therapy in beta-thalassemia intermedia. Eur J Pediatr 452. Higgs DR, Vickers MA, Wilkie AO, et al: A review of the molecular
137:267, 1981. genetics of the human alpha-globin gene cluster. Blood 73:1081, 1989.
427. Olivieri NF, Koren G, Matsui D, et al: Reduction of tissue iron stores 453. Higgs DR: Molecular mechanisms of alpha thalassemia. In Steinberg
and normalization of serum ferritin during treatment with the oral iron MH, Forget BG, Higgs DR, editors: Disorders of hemoglobin, New York,
chelator L1 in thalassemia intermedia. Blood 79:2741, 1992. 2001, Cambridge University Press, p 405.